MTOR and diabetes mellitus: Previous studies have suggested that metformin may improve oxygenation and suppress the accumulation of HIF-1α in diseases associated with tumors or diabetes through the activation of the AMPK/mTOR pathway and the repression of oxygen consumption (24–27).